Geneos Wealth Management’s Amplify CWP Enhanced Dividend Income ETF DIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$912K Buy
19,948
+8,318
+72% +$381K 0.02% 566
2026
Q1
$522K Buy
11,630
+10,136
+678% +$464K 0.01% 685
2025
Q4
$66.5K Buy
1,494
+118
+9% +$5.31K ﹤0.01% 1292
2025
Q3
$61.3K Buy
1,376
+772
+128% +$33.5K ﹤0.01% 1301
2025
Q2
$25.7K Buy
604
+204
+51% +$8.29K ﹤0.01% 1913
2025
Q1
$16.3K Buy
400
+100
+33% +$4.14K ﹤0.01% 2042
2024
Q4
$12.1K Buy
300
+255
+567% +$10.6K ﹤0.01% 1972
2024
Q3
$1.85K Hold
45
– – ﹤0.01% 2316
2024
Q2
$1.74K Hold
45
– – ﹤0.01% 1912
2024
Q1
$1.75K Hold
45
– – ﹤0.01% 1922
2023
Q4
$1.65K Buy
+45
New +$1.58K ﹤0.01% 1950
2022
Q3
– Sell
-300
Closed -$10K – 2156
2022
Q2
$10K Hold
300
– – ﹤0.01% 1934
2022
Q1
$11K Buy
+300
New +$11.1K ﹤0.01% 2038

Other funds holding DIVO

Geneos Wealth Management's DIVO Position: Q2 2026 in Review

Geneos Wealth Management increased its Amplify CWP Enhanced Dividend Income ETF (DIVO) stake by 72% in Q2 2026, buying an estimated $381K and bringing the position to 19,948 shares worth $912K. The position accounts for 0.02% of the portfolio, ranked #566.

Geneos Wealth Management first reported a position in DIVO in Q1 2022 and has held it in 13 quarters since. 408 funds tracked by Wall St. Rank hold DIVO as of Q2 2026.

  • Geneos Wealth Management held 19,948 shares of Amplify CWP Enhanced Dividend Income ETF worth $912K as of Q2 2026.
  • Geneos Wealth Management bought 8,318 Amplify CWP Enhanced Dividend Income ETF shares in Q2 2026, an estimated $381K.
  • Amplify CWP Enhanced Dividend Income ETF made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #566 holding.
  • Geneos Wealth Management first reported a position in Amplify CWP Enhanced Dividend Income ETF in Q1 2022 and has held it in 13 quarters since.
  • 408 funds tracked by Wall St. Rank held Amplify CWP Enhanced Dividend Income ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.